{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:01:47Z","timestamp":1789646507250,"version":"4.0.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009391","name":"Kafkas \u00dcniversitesi","doi-asserted-by":"publisher","award":["2024-FM-12"],"award-info":[{"award-number":["2024-FM-12"]}],"id":[{"id":"10.13039\/501100009391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108614","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:38:38Z","timestamp":1747654718000},"page":"108614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality"],"prefix":"10.1016","volume":"162","author":[{"given":"Pelin","family":"Tokal\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyzi Sinan","family":"Tokal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bioorg.2025.108614_bb0005","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3390\/ijms22147644","article-title":"Diabetes mellitus and its metabolic complications: the role of adipose tissues","volume":"22","author":"Dilworth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108614_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","article-title":"Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives","volume":"73","author":"Naim","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108614_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108614_bb0020","first-page":"586","article-title":"Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors","volume":"83","author":"Tokali","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108614_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ddr.22031","article-title":"Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors","volume":"84","author":"Tokali","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108614_bb0030","article-title":"Corrigendum: the medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: a review","volume":"355","author":"Kajal","year":"2022","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.108614_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115528","article-title":"Aldose reductase and cancer metabolism: the master regulator in the limelight","volume":"211","author":"Syamprasad","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108614_bb0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/diab.42.6.820","article-title":"Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs","volume":"42","author":"Engerman","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2025.108614_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopha.2018.10.185","article-title":"A non-invasive, multi-target approach to treat diabetic retinopathy","volume":"109","author":"Julius","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108614_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/1056-8727(92)90024-F","article-title":"The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy","volume":"6","author":"Arauz-Pacheco","year":"1992","journal-title":"J. Diabetes Complications"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108614_bb0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archopht.1990.01070110117035","article-title":"Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors","volume":"108","author":"Kador","year":"1990","journal-title":"Arch. Ophthalmol."},{"issue":"48","key":"10.1016\/j.bioorg.2025.108614_bb0060","article-title":"Novel benzoic acid derivatives bearing Quinazolin-4(3)-one ring: synthesis, characterization, and inhibition effects on \u03b1-glucosidase and \u03b1-amylase","volume":"7","author":"Tokali","year":"2022","journal-title":"ChemistrySelect"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108614_bb0065","first-page":"1117","article-title":"Synthesis and structural characterization of novel 2-Aminomethyl Quinazolin-4(3H)-ones as organic building blocks","volume":"26","author":"Tokal\u0131","year":"2022","journal-title":"Sakarya Univ. J. Sci."},{"issue":"25","key":"10.1016\/j.bioorg.2025.108614_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301158","article-title":"Synthesis and evaluation of Quinazolin-4(3)-one derivatives as multitarget metabolic enzyme inhibitors: a biochemistry-oriented drug design","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108614_bb0075","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1016\/j.arabjc.2011.05.009","article-title":"Synthesis and antihyperlipidemic activity of some novel 4-substituted-2-substitutedmethyltriazino[6,1-b]quinazolin-10-ones and 2,4-disubstituted-6,7-dimethoxy quinazoline","volume":"9","author":"Kathiravan","year":"2016","journal-title":"Arab. J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108614_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14599","article-title":"A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies","volume":"104","author":"Tokal\u0131","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108614_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301134","article-title":"Novel Quinazolinone derivatives: potential synthetic analogs for the treatment of Glaucoma, Alzheimer's disease and diabetes mellitus","volume":"20","author":"Tokali","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108614_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204191","article-title":"Carboxylate- and sulfonate-containing quinazolin-4(3H)-one rings: synthesis, characterization, and carbonic anhydrase I\u2013II and acetylcholinesterase inhibition properties","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108614_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300423","article-title":"Novel quinazoline-chromene hybrids as anticancer agents: synthesis, biological activity, molecular docking, dynamics and ADME studies","volume":"356","author":"Tokal\u0131","year":"2023","journal-title":"Arch. Pharm."},{"issue":"30","key":"10.1016\/j.bioorg.2025.108614_bb0100","doi-asserted-by":"crossref","first-page":"26425","DOI":"10.1021\/acsomega.2c02326","article-title":"Development, molecular docking, and in silico ADME evaluation of selective ALR2 inhibitors for the treatment of diabetic complications via suppression of the polyol pathway","volume":"7","author":"Imran","year":"2022","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108614_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/bios11090322","article-title":"The kinetic and analytical aspects of enzyme competitive inhibition: sensing of Tyrosinase inhibitors","volume":"11","author":"Attaallah","year":"2021","journal-title":"Biosensors (Basel)"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108614_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108614_bb0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/diacare.27.5.1153","article-title":"Natural progression of diabetic peripheral neuropathy in the Zenarestat study population","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bioorg.2025.108614_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1570180819666220922103109","article-title":"Molecular docking: principles, advances, and its applications in drug discovery","volume":"21","author":"Muhammed","year":"2024","journal-title":"Lett. Drug. Des. Discov."},{"key":"10.1016\/j.bioorg.2025.108614_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2023.e01593","article-title":"Applications of molecular docking in natural products-based drug discovery","volume":"20","author":"Asiamah","year":"2023","journal-title":"Scientific African"},{"key":"10.1016\/j.bioorg.2025.108614_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127487","article-title":"Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: in vitro and in silico approach for the treatment of diabetes-related complications","volume":"426","author":"Tokal\u0131","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.108614_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-0716-3441-7_7","article-title":"Applications of molecular dynamics simulations in drug discovery","volume":"2714","author":"AlRawashdeh","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108614_bb0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2021","journal-title":"Processes"},{"issue":"46","key":"10.1016\/j.bioorg.2025.108614_bb0145","doi-asserted-by":"crossref","first-page":"45842","DOI":"10.1021\/acsomega.4c04639","article-title":"Design and optimization of Quinazoline derivatives as potent EGFR inhibitors for lung Cancer treatment: a comprehensive QSAR, ADMET, and Molecular Modeling Investigation","volume":"9","author":"Moussaoui","year":"2024","journal-title":"ACS OMEGA"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108614_bb0150","doi-asserted-by":"crossref","first-page":"16418","DOI":"10.1038\/s41598-024-66877-2","article-title":"QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy","volume":"14","author":"Moussaoui","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108614_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134114","article-title":"Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: in vitro enzymatic inhibition, molecular modeling, and ADMET prediction","volume":"1271","author":"Zareei","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108614_bb0160","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/jm00161a033","article-title":"Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids","volume":"29","author":"Cerelli","year":"1986","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108614_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2991","article-title":"Substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors","volume":"35","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bioorg.2025.108614_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132675","article-title":"Design, synthesis, and aldose reductase inhibitory effect of some novel carboxylic acid derivatives bearing 2-substituted-6-aryloxo-pyridazinone moiety","volume":"1258","author":"Akda\u011f","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"48","key":"10.1016\/j.bioorg.2025.108614_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204050","article-title":"In vitro inhibitory activity and molecular docking study of selected natural phenolic compounds as AR and SDH inhibitors","volume":"7","author":"T\u00fcrke\u015f","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108614_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110161","article-title":"Aldose reductase with quinolone antibiotics interaction: in vitro and in silico approach of its relationship with diabetic complications","volume":"761","author":"T\u00fcrke\u015f","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.108614_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129446","article-title":"An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives","volume":"1224","author":"Sever","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108614_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139519","article-title":"Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies","volume":"1319","author":"Tokal\u0131","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108614_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140702","article-title":"Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: synthesis, characterization and in vitro & in silico biological activity studies","volume":"1322","author":"\u00c7ak\u0131r","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108614_bb0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.procbio.2023.11.029","article-title":"Cytotoxic meroterpenoids from brown alga Stypopodium schimperi (K\u00fctzing) Verlaque & Boudouresque with comprehensive molecular docking & dynamics and ADME studies","volume":"136","author":"Demirk\u0131ran","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.bioorg.2025.108614_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138998","article-title":"Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: an in vitro-in silico study","volume":"1315","author":"Petrova","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108614_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136804","article-title":"Novel chalcone derivatives of ursolic acid as acetylcholinesterase inhibitors: synthesis, characterization, biological activity, ADME prediction, molecular docking and molecular dynamics studies","volume":"1295","author":"\u015eenol","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108614_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301089","article-title":"Synthesis and anticancer activity of novel derivatives of alpha,beta-unsaturated ketones based on oleanolic acid: in vitro and in silico studies against prostate cancer cells","volume":"20","author":"\u015eenol","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108614_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.32571\/ijct.944049","article-title":"Inhibition profiles and molecular docking studies of anti-proliferative agents against aldose reductase enzyme","volume":"5","author":"K\u0131l\u0131n\u00e7","year":"2021","journal-title":"International Journal of Chemistry and Technology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:06:14Z","timestamp":1748959574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"alternative-id":["S0045206825004948"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108614","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108614"}}